Imaging of serotonin and dopamine transporters in the living human brain


Alterations in brain serotonin (5-HT) and dopamine (DA) activity are associated with several neuropsychiatric disorders, but until now it has not been possible to simultaneously visualize or quantify the 5-HT and the DA transporter density in the living human brain. In this paper we report on the imaging of 5-HT and DA transporters in 28 healthy controls with single-photon emission tomography using iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane ([123I]β-CIT) as the tracer. The [123I]β-CIT distribution showed the most prominent 5-HT activity in the medial frontal cortex, hypothalamus, midbrain and occipital cortex and the greatest DA activity in the basal ganglia. The specific binding of the 5-HT transporters in the medial frontal cortex was 0.377±0.031 and that of the DA transporters in the basal ganglia, 0.916±0.007. Gjedde-Patlak plots indicated two separate components: the first was assumed to represent 5-HT transporters with a slope of 1.29±0.27 h−1 and the second, DA transporters with a slope of 0.30±0.04 h−1. This distinct kinetic pattern and the fact that 5-HT and DA transporters are situated in different parts of the brain provides an opportunity to study in vivo patients suffering from various neuropsychiatric disorders.

DOI: 10.1007/BF00941852

4 Figures and Tables


Citations per Year

1,081 Citations

Semantic Scholar estimates that this publication has 1,081 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kuikka1995ImagingOS, title={Imaging of serotonin and dopamine transporters in the living human brain}, author={Jyrki T. Kuikka and Jari Tiihonen and Kim A. Bergstr{\"{o}m and Jari Karhu and P{\"a}ivi H Hartikainen and Heimo T Viinam{\"a}ki and Esko A. L{\"a}nsimies and Johannes Lehtonen and Panu Hakola}, journal={European Journal of Nuclear Medicine}, year={1995}, volume={22}, pages={346-350} }